文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：五味子醇乙与水飞蓟宾协同逆转小鼠肝纤维化并调节多种信号通路。

Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Modulating Multiple Signaling Pathways in Mice.

作者信息

Ai Yongqiang, Shi Wei, Zuo Xiaobin, Sun Xiaoming, Chen Yuanyuan, Wang Zhilei, Li Ruisheng, Song Xueai, Dai Wenzhang, Mu Wenqing, Ding Kaixin, Li Zhiyong, Li Qiang, Xiao Xiaohe, Zhan Xiaoyan, Bai Zhaofang

机构信息

Department of Hepatology, The Fifth Medical Centre, Chinese PLA General Hospital, Beijing, China.

Research Center for Clinical and Translational Medicine, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.

出版信息

Front Pharmacol. 2021 Oct 7;12:777914. doi: 10.3389/fphar.2021.777914. eCollection 2021.

DOI:10.3389/fphar.2021.777914

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8529232/

Abstract

[This corrects the article DOI: 10.3389/fphar.2021.655531.].

摘要

[本文更正了文章的数字对象标识符：10.3389/fphar.2021.655531。]

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6751/8529232/b4cd83ad87d4/fphar-12-777914-g005.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6751/8529232/b4cd83ad87d4/fphar-12-777914-g005.jpg

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6751/8529232/b4cd83ad87d4/fphar-12-777914-g005.jpg

相似文献

1

Corrigendum: The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Modulating Multiple Signaling Pathways in Mice.勘误：五味子醇乙与水飞蓟宾协同逆转小鼠肝纤维化并调节多种信号通路。

Front Pharmacol. 2021 Oct 7;12:777914. doi: 10.3389/fphar.2021.777914. eCollection 2021.

2

The Combination of Schisandrol B and Wedelolactone Synergistically Reverses Hepatic Fibrosis Via Modulating Multiple Signaling Pathways in Mice.五味子醇乙与水飞蓟宾协同作用通过调节小鼠多种信号通路逆转肝纤维化

Front Pharmacol. 2021 Jun 3;12:655531. doi: 10.3389/fphar.2021.655531. eCollection 2021.

3

Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.黄芪总皂苷与甘草酸通过调节TGF-β1/Smads信号通路协同发挥抗肝纤维化作用。

J Ethnopharmacol. 2016 Aug 22;190:83-90. doi: 10.1016/j.jep.2016.06.011. Epub 2016 Jun 6.

4

[Effective components of traditional Chinese medicine for regulating TGF-Beta1/Smads signaling pathway in hepatic fibrosis].[调节肝纤维化中TGF-β1/Smads信号通路的中药有效成分]

Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(4):666-674. doi: 10.19540/j.cnki.cjcmm.20181221.006.

5

HBOA ameliorates CCl-incuded liver fibrosis through inhibiting TGF-β1/Smads, NF-κB and ERK signaling pathways.HBOA 通过抑制 TGF-β1/Smads、NF-κB 和 ERK 信号通路改善 CCl 所致的肝纤维化。

Biomed Pharmacother. 2019 Jul;115:108901. doi: 10.1016/j.biopha.2019.108901. Epub 2019 May 9.

6

Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.甲基 Helicterte 通过调节 miR-21 介导的 ERK 和 TGF-β1/Smads 通路改善肝纤维化。

Int Immunopharmacol. 2019 Jan;66:41-51. doi: 10.1016/j.intimp.2018.11.006. Epub 2018 Nov 9.

7

Fusaric acid (FA) protects heart failure induced by isoproterenol (ISP) in mice through fibrosis prevention via TGF-β1/SMADs and PI3K/AKT signaling pathways.非瑟酸（FA）通过 TGF-β1/SMADs 和 PI3K/AKT 信号通路预防纤维化，从而保护异丙肾上腺素（ISP）诱导的心力衰竭小鼠。

Biomed Pharmacother. 2017 Sep;93:130-145. doi: 10.1016/j.biopha.2017.06.002. Epub 2017 Jun 16.

8

Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway.甲基紫堇醇灵通过调节 TGF-β1/Smads 通路和线粒体依赖性通路改善酒精性肝纤维化。

Int Immunopharmacol. 2019 Oct;75:105759. doi: 10.1016/j.intimp.2019.105759. Epub 2019 Jul 17.

9

Corrigendum: Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy.勘误：饮食干预诱导的非酒精性脂肪性肝炎小鼠模型中肝脏病变的进展与消退及其在药物治疗中的意义

Front Pharmacol. 2020 Feb 19;11:93. doi: 10.3389/fphar.2020.00093. eCollection 2020.

10

Corrigendum to "Methyl helicterilate ameliorates alcohol-induced hepatic fibrosis by modulating TGF-β1/Smads pathway and mitochondria-dependent pathway" [Int. Immunopharmacol. 75 (2019) 105759].《“甲基异木患子酸酯通过调节TGF-β1/Smads通路和线粒体依赖性通路改善酒精性肝纤维化”的勘误》[《国际免疫药理学》75卷（2019年）105759页]

Int Immunopharmacol. 2021 Mar;92:107344. doi: 10.1016/j.intimp.2020.107344. Epub 2021 Jan 5.